Atlas Trials

Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma

Clinical trial NCT02451488 · COMPLETED

Trial details

NCT number
NCT02451488
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Melanoma
Start date
2015-05-01
Primary completion
2016-11-04
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.